Last reviewed · How we verify

NCT05187247

VR Glasses During Induction of Labour for Pain and Anxiety Relieve

Status unknown NA Last updated 27 January 2022
What this trial tests

NA trial testing Virtual Reality glasses in Virtual Reality in 145 participants. Status unknown.

Timeline
23 November 2021
Primary endpoint
1 November 2022
31 May 2023

Quick facts

Lead sponsorWolfson Medical Center
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment145
Start date23 November 2021
Primary completion1 November 2022
Estimated completion31 May 2023
Sites1 location across Israel

Drugs / interventions tested

Conditions studied

Sponsor

Wolfson Medical Center

Who can join

Eligibility, female only, with Virtual Reality or Induction of Labor Affected Fetus / Newborn. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In the current study, The investigators aim is to test the distraction affect of "Virtual Reality" (VR) technology on pain and anxiety in pregnant women who undergo through an induction of labour with an extra-amniotic balloon catheter

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Virtual Reality glasses

Trials testing the same drug.

Other recruiting trials for Virtual Reality

Currently open trials in the same condition.

Other Wolfson Medical Center trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05187247.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing